Introduction Epilepsy, a major neurological disorder affects about 1% of the Indian
population. The discovery of noninvasive strategies for epilepsy presents a challenge for the …

Numerous neurodegenerative conditions, such as Alzheimer's, Huntington's, Parkinson's,
amyotrophic lateral sclerosis, and glioblastoma multiform are now becoming significant …

The application of nanotechnology with integration of chemical sciences is increasing
continuously in the management of diseases. The drug's physicochemical and …

The objective of the study was to target clonazepam to the brain through the intranasal
olfactory mucosa using nanolipid carriers loaded with superparamagnetic iron oxide …

Epilepsy is a chronic neurological disorder affecting 70 million people globally. One of the
fascinating attributes of brain microvasculature is the (BBB), which controls a chain of distinct …

Delivering drugs to the brain has always been a challenging task due to the restrictive
properties of the blood-brain barrier (BBB). Intranasal delivery is therefore emerging as an …

In spite of the great advance in drug delivery systems (DDSs) for the control of the
neurological disorders like Alzheimer's disease, Parkinson's disease, epilepsy and seizures …

The nasal route of administration is gaining a lot of interest these days in order to achieve
the efficient brain targeting. The superior therapeutic outcomes of nasal delivery are due to …

For the last few decades, nanocarrier strategies have endeavored to cause a revolution in
the diagnostic and therapeutic domain due to the miniature dimensions of nanoparticles …

Background: Psoriasis is a chronic autoimmune inflammatory disorder characterized by
thickened inflamed skin lesions covered with scaly patches. Psoralen is a phytoconstituent …